OTTAWA — Two vaccine builders in Canada say a scarcity of federal funding early within the pandemic saved homegrown vaccines from transferring as shortly as worldwide variations.
John Lewis, the CEO of Entos Prescription drugs in Alberta, says his firm is considered one of six that obtained about $5 million to maneuver their COVID-19 vaccine alongside.
However Lewis says different nations invested greater than $300 million per firm to make sure that they had funding to get by means of all the vaccine improvement course of.
He says these corporations, akin to AstraZeneca and Pfizer, now have vaccines accepted in dozens of nations.
Talking to the Home of Commons well being committee immediately, Lewis says Canada nonetheless has no vaccine by means of the end line.
Dr. Gary Kobinger, a microbiologist at Laval College who was a part of Canadian groups that helped develop vaccines for Ebola and Zika, says his non-profit had a vaccine with glorious early lab outcomes final February, but it surely stalled as a result of “we could not discover funding.”
This report by The Canadian Press was first revealed Feb. 22, 2021.
var addthis_config = ; jQuery(document).ready( function());
var addthis_config = ;